REG-Mydecine Innovations Group Inc: Delisting From AQSE

Mydecine InnovationsAnnouncement

21/03/2025 07:15

 

Delisting From AQSE

Vancouver, British Columbia, 21 March 2025 - Mydecine Innovations Group Inc.
(the "Company") (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) announces
that, further to the announcement of 10 October 2024, its common shares will
be withdrawn from trading on the Aquis Stock Exchange Growth Market with
effect from market open on 2 April 2025.  Consequently, the last day of
trading will be 1 April 2025 however the common shares will remain trading on
the CSE, OTC and FSE.

 

The Directors of Mydecine take responsibility for this announcement.

 

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law
by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is
disclosed in accordance with the Company's obligations under Article 17 of
MAR.

 

On behalf of the Board of Directors,

MYDECINE INNOVATIONS GROUP INC.

Joshua Bartch

Chief Executive Officer

contact@mydecineinc.com

 

AQSE Corporate Advisor

Novum Securities Limited  Tel: +44 (0)207 399 9400

David Coffman / Anastassiya Eley

 



Copyright (c) 2025 PR Newswire Association,LLC. All Rights Reserved